Clinical investigation for soluble insulin receptor ectodomain in patients with diabetes, hypertension, dislipidemia, atherosclerosis and endocrine diseases

Clinical investigation for soluble insulin receptor ectodomain in patients with diabetes, hypertension, dislipidemia, atherosclerosis and endocrine diseases - Clinical investigation for soluble insulin receptor ectodomain

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003334

Enrollment

300

Registered

2010-03-15

Start date

2008-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes, hypertension, dislipidemia, atherosclerosis and endocrine diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetes; blood glucose > 200mg/dl, Hypertension; BP > 135/85, Dislipidemia; HDL < 35 mg/dl, LDL > 140 mg/dl or TG >150mg/dl Atherosclerosis; clinical diagnosis for coronary artery disease or ASO Endocrine diseases; clinical diagnosis for endocrine diseases

Exclusion criteria

Exclusion criteria: persons who does not agree with informed concent for this study

Design outcomes

Primary

Measure	Time frame
Changes of biomarkers during the treatment for individual disorders	—

Secondary

Measure	Time frame
blood glucose, glycated albumine, hemoglobin A1c	—

Countries

Japan

Contacts

Public ContactHiroyuki Motoshima

Faculty of Life Sciences, Kumamoto University Department of Metabolic Medicine

hmoto@kumamoto-u.ac.jp096-373-5169

Outcome results